By Ethan Covey
Certain patient characteristics, as well as the use of particular antibiotics, are associated with increased rates of multiple recurrent Clostridioides difficile infections (mrCDIs), according to data presented at IDWeek 2023, held in Boston (poster 684).
The researchers focused on data from the CDC’s Emerging Infections Program (EIP), which conducts population-based CDI surveillance at sites in 10 states. CDI cases were defined as a positive C. difficile test during January